Researchers at the Center for Pediatric Nanomedicine (CPN) will design specific, nanoparticles in an endeavor to treat pediatric illnesses.
Focus will be on pediatric heart disease and thrombosis, infectious diseases, cancer, sickle cell disease and cystic fibrosis.
Gang Bao, director, will work with researchers from the Emory University, the Georgia Institute of Technology and Children’s Healthcare of Atlanta. Nano-structures, being as small as biomolecules, will enable nanomedicine to offer better control of biological processes. It will facilitate disease tracking, therapy and prevention, adds Robert A. Milton, professor of Biomedical Engineering in the Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory University. Nanomedicine helps develop fabricated nano-structures for enhanced diagnostics and medical procedures to treat diseases and mend damaged tissues.
CPN belongs to the Emory-Children’s Pediatric Research Center run by the two institutions, and collaborates with Georgia Institute of Technology and Morehouse School of Medicine. Dr. Paul Spearman, Children’s chief research officer and vice chair for research in the Emory University Department of Pediatrics, will guide the teams from 14 centers.
The areas covered will include hematology and oncology, immunology and vaccines, transplant immunology and immune therapeutics, pediatric healthcare technology innovation, cystic fibrosis, developmental lung biology, endothelial biology, cardiovascular biology; drug discovery, autism, neurosciences, nanomedicine, outcomes research and public health, and clinical and translational research.